PREVE® Secures $2.2M Seed Round to Empower World-Class Physiotherapy Clinics

PREVE® is thrilled to announce the successful raising of $2,200,000 in our latest funding round—a remarkable milestone that underscores our commitment to revolutionizing physiotherapy care. As a company dedicated to helping physiotherapy clinics deliver world-class treatment, this capital injection is set to accelerate our mission of enhancing patient outcomes worldwide. With these funds, we plan to further develop our innovative suite of tools and technologies designed to improve clinical workflows, streamline treatment protocols, and ultimately empower physiotherapists to focus on what truly matters: patient care. The investment will drive expansion of our research and development team, enabling us to integrate advanced analytics and digital health solutions that personalize and optimize therapy programs. Additionally, a portion of the funding will be allocated toward strengthening our customer support and training initiatives, ensuring that clinics adopting PREVE® can make a smooth transition to our state-of-the-art platform. Our vision is to create an ecosystem where technology and therapy coexist seamlessly, helping professionals deliver precise, effective, and compassionate care. We believe that these strategic enhancements will not only foster greater confidence among clinicians but also translate into significant improvements in patient recovery experiences. As we embark on the next phase of growth, we remain dedicated to pushing the boundaries of what is possible in rehabilitative medicine. Our team is energized by this new chapter of innovation and expansion, and we are grateful to our investors, partners, and clients for their ongoing support. Together, we are poised to transform physiotherapy and set new standards in healthcare delivery, paving the way for a healthier future for all.